The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Phorm Announces AGM Notice & Proposed Board Change

22 May 2012 07:00

RNS Number : 7593D
Phorm Inc
22 May 2012
 



22 May 2012

Phorm, Inc. ('Phorm' or 'the Company')

Phorm Announces AGM Notice and Proposed Board Change

 

AGM Notice

 

Phorm (AIM: PHRM and PHRX), today announces that it will hold its Annual General Meeting ("AGM") at 11.00 am on 19 June 2012 at Liberty House, 222 Regent Street, London, W1B 5TR.

 

The notice and proxy statement outlining details of the AGM has today been posted to shareholders and a copy of the same will be available on the investor relations section of the Phorm website (www.phorm.com).

 

Proposed Board Change

 

At the AGM it is proposed that Christopher Delorme be elected as a non-executive director of the Company and that Andrew Croxson be elected as an executive director of the Company.

 

Mr Delorme is a partner in RSR CAPITAL PTE LTD, a Singapore based investment fund. He has been in Asia for 20 years, having spent 17 years in Japan as an equity derivatives broker for FIMAT, a subsidiary of Sociéte Générale North Pacific in Tokyo. From 1995, he developed OTC (over the counter) functions for brokerage firms including Tullett and ICAP. He then returned to FIMAT in 2003 where he established them as the leading broker in OTC derivatives in Asia. He holds a BA degree from Ecole des Cadres in Paris and is fluent in French and English. Should Mr Delorme be elected at the AGM further disclosure will be made in accordance with the AIM Rules of the London Stock Exchange.

 

Andrew Croxson, Phorm's Chief Financial Officer and Chief Operating Officer, has responsibility for global finance and operations at Phorm and has been with the Company for over 3 years. Andrew has over 12 years experience working in the Technology, Media and Telecommunications ("TMT") sector. Andrew was previously Managing Director of TMT specialists Ingenious Consulting. Prior to that, he was a partner at Spectrum Strategy Consultants leading its technology practice worldwide. Andrew is an ACA qualified chartered accountant and has Masters Degrees from both Oxford and Cambridge Universities. As well as Andrew's significant financial knowledge, he also brings deep experience of advising brand leading media and technology companies and strategic insights into building and scaling global operations. Should Mr Croxson be elected at the AGM further disclosure will be made in accordance with the AIM Rules of the London Stock Exchange.

 

Stephen Partridge-Hicks' term of office comes to an end at the AGM.

 

Operationally the Company continues to make progress on all matters referred to last October and will update the market when appropriate.

 

 

For Enquiries

 

Phorm, Inc.

Mark Williams (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

 

Liberum Capital +44 20 3100 2222

(Nominated Advisor and Joint Broker)

Chris Bowman and Richard Bootle

 

Mirabaud Securities LLP +44 20 7321 2508

(Joint Broker)

Jason Woollard

Peter Krens

- ends -

 

 

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

 

A Delaware, US incorporated company, Phorm was admitted to the AIM market of the London Stock Exchange in 2004 and has over 140 employees and contractors.

 

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOAEAFSFADDAEFF
Date   Source Headline
19th Jun 20127:00 amRNSAGM Statement
1st Jun 20127:00 amRNS£20m equity fundraising into Phorm China
1st Jun 20127:00 amRNSIntention to Re-Domicile
22nd May 20127:00 amRNSPhorm Announces AGM Notice & Proposed Board Change
21st Mar 20127:00 amRNSAppointment of Nominated Adviser and Joint Broker
5th Mar 20127:00 amRNSTransfer of Shares
1st Mar 20127:00 amRNSTransfer of Shares
28th Dec 20117:00 amRNSDirector Dealing
12th Dec 201110:10 amRNSTransfer of Shares
7th Dec 201110:19 amRNSTransfer of Shares
2nd Dec 20112:02 pmRNSTR-1: Notification of Major Interest in Shares
2nd Dec 201112:16 pmRNSTransfer of Shares
11th Nov 20117:30 amRNSIssue of Equity
4th Nov 20117:30 amRNSIssue of Equity
21st Oct 20113:28 pmRNSIssue of Equity
20th Oct 20114:14 pmRNSTransfer of Shares
7th Oct 20112:00 pmRNSBlock Admission Return
30th Sep 20117:00 amRNSInterim Results for Six Months Ended 30 June 2011
28th Sep 20117:00 amRNSProduct Launch
30th Jun 20117:00 amRNSAnnual Financial Report
8th Apr 201112:00 pmRNSBlock Admission Return
30th Mar 20117:00 amRNSTR-1: Notification of Major Interest in Shares
22nd Mar 20117:00 amRNSPlacing and operating update
2nd Mar 201112:00 pmRNSTransfer of Shares
1st Feb 201110:14 amRNSResult of AGM
6th Jan 20117:15 amRNSOption Grant and Modification
6th Jan 20117:05 amRNSAdvisory Board Appointment - Juan Villalonga
24th Dec 20108:11 amRNSNotice of AGM
17th Dec 20109:11 amRNSIssue of convertible secured loan notes
8th Oct 20105:25 pmRNSBlock Admission Return
30th Sep 20107:00 amRNSInterim results
22nd Sep 20107:00 amRNSUpdate on Commercial Deployment in Brazil
17th Aug 20103:42 pmRNSCorrection re Share Transfer
16th Aug 20103:58 pmRNSShare Transfer
16th Aug 20108:50 amRNSDirectorate Change
30th Jul 20101:00 pmRNSTransfer of Shares
23rd Jul 201011:17 amRNSDirectorate Change
16th Jul 20104:25 pmRNSTransfer of Shares
9th Jul 20107:00 amRNSTransfer of Shares
7th Jul 20104:55 pmRNSDirector/PDMR Shareholding
7th Jul 20102:19 pmRNSPlacing of Shares
30th Jun 20102:17 pmRNSAnnual Report & Accounts Notification
30th Jun 20107:00 amRNSPreliminary Results
28th Jun 20107:00 amRNSNotification of results
8th Jun 20102:05 pmRNSChange in name of Nominated Adviser
30th Apr 20101:08 pmRNSGrant of options
9th Apr 20105:25 pmRNSBlock Admission Return
26th Mar 20107:00 amRNSCommercial Deployment in Brazil
28th Jan 20104:37 pmRNSNotification of Major Interest in Shares
11th Jan 20104:28 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.